Position in FDMT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$38,717,749
+$13,507,433 QoQ
Shares Held
2,911,109
+7.5% QoQ
Ownership
4.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,547,261,981 across 411 Biotechnology names. FDMT ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in FDMT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,717,749 | 2,911,109 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $25,210,316 | 2,707,875 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $25,210,316 | 2,707,875 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,166,600 | 2,688,880 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,853,796 | 903,774 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,568,879 | 961,962 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,320,278 | 1,027,950 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,197,867 | 1,112,723 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,879,451 | 2,116,508 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $43,644,003 | 2,079,276 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $69,398,407 | 2,178,230 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $30,876,037 | 1,523,990 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,858,937 | 1,717,120 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $37,051,270 | 2,050,430 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $35,105,228 | 2,042,189 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,432,859 | 1,235,158 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $5,444,495 | 677,176 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,415,024 | 632,525 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,519,289 | 1,489,371 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,636,940 | 1,259,660 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,621,284 | 319,662 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,985,047 | 165,492 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,634,415 | 106,833 | Shares | Defined | 2021-07-09 | |
| No filing history on record for this holder in this stock. | ||||||